|
MLLT4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.48330303174316E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.66799999946311E-07 |
| Normal-vs-Stage2 |
1.030230E-04 |
| Normal-vs-Stage3 |
5.01820807130571E-14 |
| Normal-vs-Stage4 |
6.54065690497418E-12 |
| Stage1-vs-Stage2 |
3.803800E-01 |
| Stage1-vs-Stage3 |
1.004190E-04 |
| Stage1-vs-Stage4 |
4.044500E-04 |
| Stage2-vs-Stage3 |
1.451990E-01 |
| Stage2-vs-Stage4 |
6.553700E-02 |
| Stage3-vs-Stage4 |
5.202400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.5657036191501E-11 |
| Normal-vs-AfricanAmerican |
1.436190E-02 |
| Normal-vs-Asian |
5.168300E-02 |
| Caucasian-vs-AfricanAmerican |
6.476100E-02 |
| Caucasian-vs-Asian |
5.925400E-01 |
| AfricanAmerican-vs-Asian |
7.672800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97960553399912E-11 |
| Normal-vs-Female |
9.63139999976548E-08 |
| Male-vs-Female |
1.729160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.496200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.13899999724055E-08 |
| Normal-vs-Age(61-80Yrs) |
3.53689966203774E-10 |
| Normal-vs-Age(81-100Yrs) |
4.32720000054232E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.427800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.755400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.419780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.864580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.033600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.815600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.442400E-01 |
| Normal-vs-Grade 2 |
2.06019999999807E-05 |
| Normal-vs-Grade 3 |
1.626032641866E-12 |
| Normal-vs-Grade 4 |
1.62492241884138E-12 |
| Grade 1-vs-Grade 2 |
8.799200E-03 |
| Grade 1-vs-Grade 3 |
2.175400E-03 |
| Grade 1-vs-Grade 4 |
4.57119999630606E-08 |
| Grade 2-vs-Grade 3 |
3.93480000004942E-06 |
| Grade 2-vs-Grade 4 |
6.142400033049E-09 |
| Grade 3-vs-Grade 4 |
7.404700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.01150000000272E-05 |
| Normal-vs-ccB subtype |
3.6964986627197E-11 |
| ccA subtype-vs-ccB subtype |
2.596800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.44649997430224E-09 |
| Normal-vs-N1 |
5.237000E-03 |
| N0-vs-N1 |
2.127600E-01 |
|
|
